Sam Schulman

Posts

Management of bleeding complications in cancer patients on DOACs
Anticoagulation Drugs

Management of bleeding complications in cancer patients on DOACs

Major bleeding can be life or limb threatening and incurs substantial health care costs, whereas clinically relevant non-major bleeds are mainly very disturbing for the patients and may reduce their quality of life. Bleeding in patients with anticoagulation for venous thromboembolism (VTE) the incidence is front-loaded. Patients with a major bleeding are usually not given extended anticoagulant treatment.

Read More